Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
67.00
Ask:
73.00
Spread: 6.00 (8.955%)
Market Cap: £180.27m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Interim Management Statement

29 Jan 2021 10:37

RNS Number : 3696N
Unicorn AIM VCT PLC
29 January 2021
 

Unicorn AIM VCT plc ("the Company")

Interim Management Statement 

For the period from 1 October 2020 to 31 December 2020

 

Introduction

This voluntary Interim Management Statement (IMS) covers the three month period ended 31 December 2020, together with relevant information up to the date of publication. 

 

Investment Objective

The Company's objective is to provide Shareholders with an attractive return from a diversified portfolio of investments, predominantly in the shares of AIM quoted companies, by maintaining a steady flow of dividend distributions to Shareholders from the income as well as capital gains generated by the portfolio.

 

It is also the objective that the Company should continue to qualify as a Venture Capital Trust ("VCT"), so that Shareholders benefit from the taxation advantages that this brings. To achieve this, at least 80% for accounting periods commencing on or after 6 April 2019 (previously 70%) of the Company's total assets are to be invested in qualifying investments of which 70% by VCT value (30% in respect of investments made before 6 April 2018 from funds raised before 6 April 2011) must be in ordinary shares, which carry no preferential rights (save as permitted under VCT rules) to dividends or return of capital and no rights to redemption.

 

Performance  

The performance of the Company's diverse portfolio of investments, has been largely positive during the first quarter of the Company's current financial year. Net asset value per share increased significantly, as many of the companies held in the portfolio issued encouraging trading updates which, in turn, triggered some impressive share price gains.

 

As at 31 December 2020, the unaudited net asset value was 204.5 pence per share, which represents an increase of +14.5% on the audited closing net asset value of 178.6 pence per share as at 30 September 2020. UK equity indices also continued their recovery from the significant equity market correction experienced during March 2020, with the FTSE AIM All-Share Index generating a total return of +20.9%, while the FTSE AllShare Index delivered a total return of +12.6% over the same period.

 

The portfolio remains predominantly composed of investments in businesses listed on the Alternative Investment Market (AIM). Many of these investee companies are relatively mature and, as such, most have them have remained profitable throughout the difficulties experienced during 2020.

 

Encouragingly, the pipeline of investment opportunities has strengthened since the start of October, and all key HMRC tests continued to be met. At the period end, an estimated 85.4% of total assets (assessed in accordance with VCT rules) were invested in VCT qualifying companies.

 

Despite the increased risks associated with early-stage investment and the uncertainty created by the ongoing pandemic, the Investment Manager is confident that the portfolio, as a whole, offers the prospect of delivering attractive total returns over the longer term.

 

Material Transactions

During the period under review, four new VCT qualifying investments, costing £6.3 million, were completed. No follow-on VCT qualifying investments were made.

 

Approximately £0.4 million was raised from the partial disposal of one holding during the period. In addition, one holding was disposed of in full, realising proceeds of approximately £1.4 million. The usual purpose of such disposals is threefold; to ensure stock specific risk is contained, to lock in capital profits for future distribution to shareholders via dividend payments and to help manage liquidity requirements.

 

Top Ten VCT Qualifying Holdings as at 31 December 2020

Stock

% of fund

Interactive Investor

10.7%

Hasgrove

9.6%

Abcam

6.4%

MaxCyte Inc

5.3%

Tracsis

3.5%

Anpario

3.2%

Tristel

2.9%

Surface Transforms

2.7%

Cohort

2.5%

Mattioli Woods

2.4%

Total

49.2%

 

Share Buy-Backs

During the period from 1 October to 31 December 2020, the Company bought back 770,517 of its own Ordinary Shares for cancellation, at an average price of 162 pence per share. As at 31 December 2020, there were 144,962,024 Ordinary Shares in issue. After the period end, a further 131,796 Ordinary Shares were purchased for cancellation at a price of 174.5 pence per share.

 

Dividends & Annual General Meeting

As previously advised, the Board declared a final dividend of 3.5 pence per share in respect of the Company's financial year ended 30 September 2020. This final dividend will be paid on 11 February 2021 to Shareholders who were on the register on 8 January 2021, subject to receiving approval from shareholders at the Annual General Meeting of the Company, which is to be held on 4 February 2021, in a closed format due to the ongoing Covid-19 pandemic.

 

Material Events

There were no material events during the period under review.

An Offer for Subscription, to raise up to £15 million of new capital, opened on 28 January 2021 and will close for applications on 29 March 2021, or earlier, if fully subscribed.

 

Chris Hutchinson

Director, Unicorn Asset Management

 

29 January 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFZGZMGLKGMZM
Date   Source Headline
5th Jul 20165:27 pmRNSNet Asset Value(s)
6th Jun 20165:03 pmRNSNet Asset Value(s)
1st Jun 201611:30 amRNSTotal Voting Rights
18th May 20167:00 amRNSHalf-year Report to 31 March 2016
13th May 201612:20 pmRNSTransaction in Own Shares
5th May 20165:50 pmRNSNet Asset Value(s)
3rd May 201611:48 amRNSTotal Voting Rights
7th Apr 20165:04 pmRNSTransaction in Own Shares
7th Apr 201610:11 amRNSTotal Voting Rights
7th Apr 20169:55 amRNSIssue of Equity
7th Apr 20167:00 amRNSCompliance with Model Code
5th Apr 20164:06 pmRNSNet Asset Value(s)
1st Apr 201610:06 amRNSTotal Voting Rights 31 March 2016
4th Mar 20161:14 pmRNSDirector/PDMR Shareholding
4th Mar 201611:57 amRNSDirector/PDMR Shareholding
2nd Mar 20165:24 pmRNSTotal Voting Rights
2nd Mar 20163:46 pmRNSIssue of Equity
1st Mar 20165:11 pmRNSTransaction in Own Shares
1st Mar 201612:09 pmRNSNet Asset Value 29 February 2016
1st Mar 20168:30 amRNSTotal Voting Rights 29 February 2016
24th Feb 20163:08 pmRNSStatement re Home Member State
22nd Feb 201612:07 pmRNSOffer for Subscription - Update
11th Feb 20162:28 pmRNSIssue of Equity
11th Feb 20161:48 pmRNSResult of AGM
8th Feb 201610:40 amRNSNet Asset Value 31 Janaury 2016
2nd Feb 20162:42 pmRNSOffer for Subscription and Issue of Prospectus
1st Feb 20162:11 pmRNSTotal Voting Rights
14th Jan 20161:09 pmRNSInterim Management Statement
14th Jan 20161:01 pmRNSIntention to launch an offer
13th Jan 20161:34 pmRNSTransaction in Own Shares
12th Jan 20163:10 pmRNSTotal Voting Rights
12th Jan 20163:05 pmRNSMerger Results
6th Jan 20163:24 pmRNSNet Asset Value 31 December 2015
11th Dec 20159:55 amRNSAnnual Financial Report 30 September 2015
3rd Dec 20159:48 amRNSNet Asset Value 30 November 2015
1st Dec 20151:09 pmRNSTotal Voting Rights
20th Nov 20151:44 pmRNSDirector/PDMR Shareholding
11th Nov 201510:45 amRNSTransaction in Own Shares
3rd Nov 20155:13 pmRNSNet Asset Value 31 October 2015
27th Oct 20153:00 pmRNSUpdate on Proposed Acquisition of Assets
12th Oct 20152:18 pmRNSCompliance with Model Code
2nd Oct 20153:31 pmRNSNet Asset Value(s)
1st Oct 201512:32 pmRNSTotal Voting Rights
4th Sep 20159:08 amRNSTransaction in Own Shares
2nd Sep 20155:28 pmRNSNet Asset Value(s)
14th Aug 201512:42 pmRNSResult of General Meeting
5th Aug 20157:38 amRNSNet Asset Value(s)
3rd Aug 20159:41 amRNSTotal Voting Rights
28th Jul 201510:56 amRNSInterim Management Statement
17th Jul 20153:00 pmRNSProposed Acquisition of Assets

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.